Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 23, Pages 5949
Publisher
MDPI AG
Online
2022-12-01
DOI
10.3390/cancers14235949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blinatumomab Induces Complete Response in Refractory PTLD after Hematopoietic Cell Transplantation
- (2022) Sanyukta Janardan et al. Blood Advances
- Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
- (2022) Rabea Asleh et al. Frontiers in Cardiovascular Medicine
- Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
- (2022) Heiner Zimmermann et al. LEUKEMIA
- Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients
- (2022) Madeleine R. Heldman et al. Transplant Infectious Disease
- Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders–diffuse large B-cell lymphoma
- (2021) Jwa Hoon Kim et al. Scientific Reports
- Joining Efforts for PTLD: Lessons Learned from Comparing the Approach and Treatment Strategies Across the Pediatric and Adult Age Spectra
- (2021) Francesca Montanari et al. Current Hematologic Malignancy Reports
- Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein–Barr Virus (EBV) Assessments—A Single Tertiary Referral Center Experience and Review of Literature
- (2021) Eric Lau et al. Cancers
- Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT
- (2021) Toby A. Eyre et al. BONE MARROW TRANSPLANTATION
- Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients
- (2021) Mary M. Taj et al. BRITISH JOURNAL OF HAEMATOLOGY
- Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline
- (2021) Nimish Shah et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database
- (2021) Chien‐Chang Lee et al. ONCOLOGIST
- Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
- (2021) Nan Yan et al. Frontiers in Oncology
- Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group Survey
- (2021) Alastair Baker et al. Children-Basel
- Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial
- (2021) Sridhar Chaganti et al. BLOOD
- Overall Survival By Best Overall Response with Tabelecleucel in Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ or Allogeneic Hematopoietic Cell Transplant
- (2021) Susan Prockop et al. BLOOD
- Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)
- (2021) Susan Prockop et al. BLOOD
- Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
- (2021) Elham Ahmadi et al. Virology Journal
- CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review
- (2021) Rafael Hernani et al. Current Research in Translational Medicine
- CD30 expression and survival in posttransplant lymphoproliferative disorders
- (2020) Amelie Kinch et al. ACTA ONCOLOGICA
- A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) As Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas
- (2020) William Pearse et al. BLOOD
- Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients
- (2020) Chakra P. Chaulagain et al. Clinical Lymphoma Myeloma & Leukemia
- Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
- (2020) Valeria Ferla et al. Frontiers in Oncology
- Central Nervous System Post-transplant Lymphoproliferative Disorder: Response to Ibrutinib
- (2020) Avyakta Kallam et al. Clinical Lymphoma Myeloma & Leukemia
- CAR‐T therapy in Solid Organ Transplant Recipients with Treatment Refractory Post Transplant Lymphoproliferative Disorder
- (2020) Sambhavi Krishnamoorthy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes
- (2020) Ryan J. Stubbins et al. LEUKEMIA & LYMPHOMA
- Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives
- (2020) Francesca Compagno et al. Frontiers in Immunology
- Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
- (2020) Danai Dima et al. Cancer Management and Research
- Safety and Efficacy of CAR T-Cell Therapy in Kidney Transplant Recipients
- (2020) Omar Mamlouk et al. BLOOD
- Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
- (2020) Efrat Luttwak et al. BONE MARROW TRANSPLANTATION
- Role of Radiotherapy in Post-transplant Lymphoproliferative Disorders: Three Case Reports and Review of the Literature
- (2020) Erika Orlandi et al. Clinical Lymphoma Myeloma & Leukemia
- Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
- (2019) Ayumi Fujimoto et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk factors and clinical outcomes of Epstein–Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies
- (2019) Xiao-Ning Gao et al. ANNALS OF HEMATOLOGY
- Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Upton D. Allen et al. CLINICAL TRANSPLANTATION
- Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study
- (2019) Seema Naik et al. Transplant Infectious Disease
- Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
- (2019) Susan Prockop et al. JOURNAL OF CLINICAL INVESTIGATION
- Management of post-transplant lymphoproliferative disorders
- (2018) Christin B. DeStefano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of the posttransplant lymphoproliferative disorder subtype on survival
- (2018) Jean L. Koff et al. CANCER
- Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder
- (2018) Amit Kalra et al. CYTOTHERAPY
- Post-Transplantation Lymphoproliferative Disorders in Adults
- (2018) Daan Dierickx et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years
- (2018) Anthea C. Peters et al. TRANSPLANTATION
- Different causes of early and late-onset post transplant lymphoproliferative disorder in kidney transplantation patients after 2000
- (2018) Jun Gyo Gwon et al. Asian Journal of Surgery
- Allograft rejection associated with immunosuppression reduction for post-transplant lymphoproliferative disorder: A 20-year single-institutional experience
- (2017) A.J. Franke et al. HEMATOLOGICAL ONCOLOGY
- Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
- (2017) Ralf U. Trappe et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcome of Epstein–Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT
- (2017) Amelie Kinch et al. LEUKEMIA & LYMPHOMA
- Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma
- (2017) Julie Morscio et al. MODERN PATHOLOGY
- Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy
- (2017) Marisa Granato et al. Scientific Reports
- Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival
- (2016) Aaron S. Rosenberg et al. AMERICAN JOURNAL OF HEMATOLOGY
- EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features
- (2016) J. Finalet Ferreiro et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression
- (2016) R. J. Jones et al. CLINICAL CANCER RESEARCH
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
- (2016) J. Styczynski et al. HAEMATOLOGICA
- EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations
- (2016) Elizabeth L Courville et al. MODERN PATHOLOGY
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
- (2016) J. Styczynski et al. HAEMATOLOGICA
- International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial
- (2015) R. U. Trappe et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Radioimmunotherapy (90Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab
- (2015) J. Rossignol et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
- (2015) M. R. Luskin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- How I treat posttransplant lymphoproliferative disorders
- (2015) D. Dierickx et al. BLOOD
- Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study
- (2015) M Wu et al. BONE MARROW TRANSPLANTATION
- Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment
- (2015) Maria Raffaella Petrara et al. CANCER LETTERS
- Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders
- (2015) Maja Ølholm Vase et al. LEUKEMIA & LYMPHOMA
- Adapted Treatment of Epstein-Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation
- (2014) S. Choquet et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
- (2014) R. San-Juan et al. CLINICAL MICROBIOLOGY AND INFECTION
- Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
- (2014) Şule Mine Bakanay et al. Turkish Journal of Hematology
- Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders
- (2013) J. Morscio et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
- (2013) A. M. Evens et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
- (2013) L Rasche et al. BONE MARROW TRANSPLANTATION
- Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
- (2013) Jan Styczynski et al. CLINICAL INFECTIOUS DISEASES
- The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder
- (2013) D. Dierickx et al. HAEMATOLOGICA
- Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
- (2013) M. Uhlin et al. HAEMATOLOGICA
- Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition
- (2013) Henry H. Balfour et al. JOURNAL OF INFECTIOUS DISEASES
- Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
- (2013) David Cunningham et al. LANCET
- Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases
- (2013) An Herreman et al. LEUKEMIA & LYMPHOMA
- Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients
- (2013) Meghan Karuturi et al. TRANSPLANT INTERNATIONAL
- Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States
- (2012) V. R. Dharnidharka et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Burkitt post-transplantation lymphoma in adult solid organ transplant recipients
- (2012) Heiner Zimmermann et al. CANCER
- Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment
- (2012) Thomas S.Y. Chan et al. CLINICAL TRANSPLANTATION
- Plasmablastic Posttransplant Lymphoma
- (2012) Heiner Zimmermann et al. TRANSPLANTATION
- Epidemiology of Posttransplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients
- (2012) Muir Morton et al. TRANSPLANTATION
- Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★
- (2011) R. Reshef et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy
- (2011) J. P. Nourse et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases
- (2011) R. Trappe et al. HAEMATOLOGICA
- Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
- (2011) Ralf Trappe et al. LANCET ONCOLOGY
- Racial Variation in the Development of Posttransplant Lymphoproliferative Disorders After Renal Transplantation
- (2011) Robert Nee et al. TRANSPLANTATION
- Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma
- (2010) Andrea Rinaldi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines
- (2010) Anne Parker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
- (2010) Andrew M. Evens et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Early Development of Hexadecyloxypropyl-cidofovir: An Oral Antipoxvirus Nucleoside Phosphonate
- (2010) Karl Y. Hostetler Viruses-Basel
- Posttransplant Lymphoproliferative Disease in Liver Transplant Patients
- (2010) Christina Hartmann et al. Current Infectious Disease Reports
- Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation
- (2009) Anne H. Blaes et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Viral disease prevention after hematopoietic cell transplantation
- (2009) J Zaia et al. BONE MARROW TRANSPLANTATION
- Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center
- (2009) Jason S. Knight et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
- (2009) J. Styczynski et al. Transplant Infectious Disease
- Epidemiology of Pretransplant EBV and CMV Serostatus in Relation to Posttransplant Non-Hodgkin Lymphoma
- (2009) Gerhard Opelz et al. TRANSPLANTATION
- Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids
- (2008) R. A. McDonald et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two-Arm Prospective Trial
- (2008) D. E. Tsai et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
- (2008) J Styczynski et al. BONE MARROW TRANSPLANTATION
- Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology
- (2008) Efsevia Vakiani et al. HEMATOLOGICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now